Core Viewpoint - Heze China (603122) announced that it has completed an investigation into abnormal stock trading fluctuations and will resume trading on November 20 [1] Group 1: Company Operations - The company confirmed that its daily operations are normal and there have been no significant changes in the internal and external operating environment [1] - As of the announcement date, there are no major undisclosed matters that could affect the abnormal fluctuations in the company's stock price [1]

格隆汇11月20日｜合富中国今日复牌后再度涨停，录得15天13板，15个交易日累计涨超290%。 ...

Group 1 - The core point of the article highlights that A-share company Hefei China has resumed trading and reached a daily limit increase, marking its 13th consecutive trading day of gains, with a total increase of over 290% in 15 trading days [1]

Group 1 - The stock price of HeFu China reached a historical high, increasing by 7.98% to 25.70 yuan, with a trading volume of 78.84 million shares and a transaction amount of 1.974 billion yuan, resulting in a turnover rate of 19.81% [2] - The latest total market capitalization of HeFu China in the A-share market is 10.23 billion yuan, with the same amount for the circulating market capitalization [2] - In the pharmaceutical and biotechnology industry, the overall decline is 0.55%, with 73 stocks rising, including HeFu China, which ranks among the top gainers [2] Group 2 - The third-quarter report indicates that HeFu China achieved an operating revenue of 549 million yuan, a year-on-year decrease of 22.80%, and a net profit of -12.3862 million yuan, a year-on-year decline of 146.65%, with a basic earnings per share of -0.0300 yuan [2]

Core Viewpoint - The company, HeFu China, experienced a significant stock performance on its first day of resuming trading, hitting the daily limit up and achieving a remarkable record of 13 trading days with gains in 15 days, with a total transaction volume exceeding 2.1 billion yuan [1] Group 1 - HeFu China's stock price reached the daily limit on its first trading day after resuming [1] - The company recorded a total of 13 trading days with gains out of the last 15 days [1] - The total transaction volume for HeFu China exceeded 2.1 billion yuan [1]

Group 1 - The core point of the article is that China Evergrande Group has resumed trading and has reached a limit-up, marking its 13th consecutive trading day of gains within a 15-day period [1]

Core Viewpoint - The stock of HeFu China resumed trading on November 20, 2025, after a suspension, experiencing a significant price increase of over 9% at one point and currently up by more than 6% [1]. Group 1: Stock Performance - HeFu China was suspended from trading on November 17, 2025, after achieving 12 out of 14 consecutive trading days with price limits [2]. - The stock recorded a cumulative increase of 256.29% during the 14-day period, significantly outperforming the industry and the Shanghai Composite Index [4]. Group 2: Financial Status - The company announced that its main business remains unchanged but is currently in a loss position, with a net profit attributable to shareholders of -5.048 million yuan for the third quarter of 2025 [4]. - The latest price-to-earnings ratio stands at 343.67, which is considerably higher than that of peer companies in the industry [4]. Group 3: Investor Advisory - The company has cautioned investors to be aware of performance volatility and the risks associated with high valuation, urging rational investment and attention to trading risks [4].

交易行情显示，11月20日，合富中国平盘开盘，开盘后股价迅速抬升，盘中一度涨超9%。截至北京商 报记者发稿，合富中国报25.46元/股，涨幅为6.97%。 北京商报讯（记者 丁宁）11月20日，合富中国（603122）复牌后股价再度大涨，盘中一度逼近涨停。 ...

Group 1 - The market focus stocks include HeFu China, which has seen a 14-day streak of 12 consecutive gains, opening flat [1] - Local stock Jiumuwang from Fujian opened up by 7.11% with a 6-day gain streak [1] - Aerospace Development, with a 4-day gain streak, opened at the daily limit [1] Group 2 - The actual controller change in Zhenai Meijia led to a 0.18% increase at the opening, maintaining a 6-day gain streak [1] - Perovskite concept stock Guosheng Technology opened flat, having a streak of 8 days with 6 gains [1] - Aquaculture stock Zhongshui Fishery reached the daily limit with a 4-day gain streak [1] Group 3 - Kaolin material concept stock Huaci Co., Ltd. opened down by 2.29% with a 4-day gain streak [1] - AI application concept stocks Rongji Software and Inspur Software opened up by 7.87% and 7.01% respectively, both with a 3-day gain streak [1] - Lithium extraction from salt lake concept stock Jinyuan Co., Ltd. reached the daily limit with a 3-day gain streak [1]

11月19日盘后，合富中国（603122）发布股票交易停牌核查结果暨复牌公告，公司股票将于2025年11月20日（星期四）复牌。 | 证券代码 | 证券简称 | 停复牌类型 | 停牌起 | 停牌 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | | | | | 始日 | 期间 | | | | 603122 | 合富中国 | A 股 复牌 | | | 2025/11/19 | 2025/11/20 | 公告显示，自2025年10月28日至2025年11月14日期间，公司股票连续十四个交易日中有十二个交易日以涨停价收盘，并5次触及股价异常波动、3次触及严 重异常波动情形，期间累计涨幅高达256.29%。 合富中国提醒，股价短期内连续上涨，存在市场情绪过热、非理性炒作风险，随时存在快速下跌可能。 截至停牌前最后一个交易日，即11月14日，合富中国股价报23.80元/股，当天涨幅达7.69%，总市值为94.74亿元。 期间累计涨幅高达256.29% 回溯来看，合富中国的本轮行情始于10月28日。自10月28日至11月14日期间，合富中国股票连续十四 ...